JCM
BNGO icon

Jacobi Capital Management’s Bionano Genomics BNGO Stock Holding History

Jacobi Capital Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11
Closed -$48K – 1441
2021
Q2 		$48K Sell
11
-25
-69% -$98.7K 0.01% 631
2021
Q1 		$174K Buy
+36
New +$203K 0.03% 370

Other funds holding BNGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Jacobi Capital Management's BNGO Position: Q3 2021 in Review

Jacobi Capital Management sold out of Bionano Genomics (BNGO) in Q3 2021, closing a stake of 11 shares — an estimated $48K sold.

Jacobi Capital Management first reported a position in BNGO in Q1 2021 and held it in 2 quarters. The position peaked at $174K in Q1 2021. 147 funds tracked by Wall St. Rank hold BNGO as of Q3 2021.

  • Jacobi Capital Management reported no remaining Bionano Genomics position as of Q3 2021 after selling out during the quarter.
  • Jacobi Capital Management sold 11 Bionano Genomics shares in Q3 2021, an estimated $48K.
  • Jacobi Capital Management first reported a position in Bionano Genomics in Q1 2021 and held it in 2 quarters.
  • Jacobi Capital Management's Bionano Genomics position peaked at $174K in Q1 2021.
  • 147 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2021.

Based on Jacobi Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.